The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
- Conditions
- Androgenic Alopecia
- Interventions
- Other: stem cell component extract
- Registration Number
- NCT02594046
- Lead Sponsor
- Pusan National University Hospital
- Brief Summary
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.
- Detailed Description
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 38
- androgenic alopecia basic and specific(BASP) classification: M2, C2, U1, V1, or F1 or higher
- patient of scalp disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description stem cell group stem cell component extract stem cell group who apply 1.2 g of allogeneic human adipose derived stem cell component extract on their scalp for 16 weeks placebo group stem cell component extract placebo group who apply a placebo on their scalp for 16 weeks
- Primary Outcome Measures
Name Time Method change of total hair counts by phototrichogram 16 weeks
- Secondary Outcome Measures
Name Time Method